The American Medical Device Summit 2025 made one thing clear: the medical device industry is entering a transformative era defined by AI-driven innovation, speed to market and user-centric design against a backdrop of increasing regulatory complexity.
From discussions on cross-functional collaboration in advanced imaging to workshops on digital engineering and predictive analytics, the message is consistent: organisations must innovate faster and smarter while maintaining an uncompromising focus on quality.
The Challenge: Complexity Meets Speed
Medical device companies face mounting pressure to deliver breakthrough technologies whilst navigating evolving regulatory frameworks in areas such as AI and Cybersecurity, while continuing to work within traditional FDA, EU MDR, and global compliance standards. Add to this the integration of software as a medical device (SaMD), AI, cloud ecosystems and the blurring of the line between digital health and wellness platforms, and the R&D landscape becomes increasingly complex.
Key themes from the Summit
1. AI and Automation in R&D
Johnson and Johnson and L&T Technology Services were among the attendees who delivered sessions dedicated to the transformation AI is having on design, testing and compliance in product delivery – whether that be in agentic AI application or using AI to digitise your QMS. These technologies promise faster development cycles and improved quality, but require robust strategies for validation and regulatory acceptance.
2. Cross-Functional Collaboration
It was great to see a focus on cross-functional collaboration at the AMDS. GE Healthcare emphasised the integration of software and hardware teams to deliver next-generation imaging technologies, whilst Fresenius Medical Care demonstrated how multidisciplinary collaboration accelerates patient-focused solutions.
Effective workflow development requires inter-departmental alignment and cross-functional collaboration. Interdisciplinary alignment, between engineering, regulatory, clinical and user experience teams, ensures that every stakeholder is engaged from concept to launch, promoting collaboration, accelerating development and minimising costs.
3. Digital Engineering and Simulation
Digital engineering and the use of simulation tools and in-silico models are becoming increasingly accessible and widespread, and play an essential role in many engineering disciplines. Generating innovative concepts using these tools can accelerate innovation by allowing engineers to model concepts, understand the constraints in each simulation and de-risk the development, prior to creating prototypes.
The role of computational modelling and in-silico trials in reducing reliance on physical prototypes was a focal point of Ansys’ workshop, in which they heralded this approach in cutting time-to-market while maintaining safety and compliance.
4. Global Regulatory Strategy
There was a definite emphasis on the importance of proactive regulatory planning at the AMDS. This was underscored by Zimmer Biomet’s plenary, “Navigating FDA Regulations and Ensuring Compliance in a Complex Medical Device Landscape”, and Smith & Nephew’s session on EU MDR impacts. Meeting the legal requirements for placing medical devices on the market requires a much broader view of the whole product life-cycle, covering not only the development but manufacture, clinical evaluation and post-market surveillance. It is therefore critical for companies that are aiming to scale globally to actively establish a regulatory strategy to avoid facing delays in their outputs.
5. Patient-Centric Design and Data Integration
Innovation must be intuitive and usable and as such, there is a noticeable shift in companies moving from a product-centric to experience-centric approach. Embedding usability engineering early in your development process is a surefire way to ensure your medical devices and digital health solutions are prepared for clinical evaluations. Integrating Voice of Customer work, formative and summative usability testing, human factors and risk-based design principles into workflows, creates closed-loop feedback allowing iterations to be insight-led, resulting in a better overall product.
Baxter International shared how engineering advancements and customer insights can align technology with real-world clinical needs. They used their case study on the Novum IQ Infusion Platform to demonstrate how competitive advantage can be delivered through improved patient outcomes.
Why R&D Partnerships Matter
For large MedTech or Pharma organisations, scaling innovation while remaining agile is a critical competitive advantage. Achieving this balance often requires strategic partnerships with experienced development teams that can bring specialised expertise and accelerate progress.
A trusted partner offers deep technical knowledge across hardware, software and integrated systems, guiding projects from concept through to commercialisation. By embedding regulatory considerations early in the design process, these collaborations help reduce risk and streamline approvals, ensuring compliance without slowing innovation.
Advanced capabilities such as rapid prototyping, digital engineering and usability testing enable faster development cycles whilst maintaining the highest standards of quality. Acting as an extension of internal R&D teams, the right partner fosters seamless communication and alignment across global stakeholders, creating a collaborative environment that drives efficiency and innovation.
Looking Ahead
As the summit discussions showed, data-driven insights, AI-enabled design and user-centric innovation are expected to play an instrumental part in shaping MedTech’s future landscape. In turn, organisations that embrace strategic partnerships will not only keep pace with change but lead it.
Ready to accelerate your innovation?
eg technology is a specialist design, engineering and development partner who can act either as an extension to your own R&D team, or as a fully ‘outsourced resource’.
User-centric innovation is not new to us. Our human-centred design approach integrates user insight from the outset, by identifying stakeholder pain points, minimising assumptions, capturing clinical complexity and enabling effective automation, thus aligning product development with clinical workflows.
With deep experience navigating the challenges of scaling, our team know how to address fragmented developments by implementing cross-functional collaboration and embedding agility and feedback into every stage of development.
The team at eg also continuously monitors the development of AI and the legislative frameworks that are being put in place for the incorporation of AI into the medical software and device development processes. With our background in developing medical devices, we understand the rigour and necessary procedures required to bring a successful medical product to market. Our highly experienced software team are also skilled at integrating AI technologies into operations workflows to optimise complex architecture and create efficiencies.
At eg technology, we are dedicated to delivering intuitive, compliant and technically robust devices that integrate seamlessly into clinical environments.
Get in touch
Please get in touch to discuss partnering with eg technology and find out how we can help you deliver smarter, safer and more impactful medical devices.
Contact us via email on design@egtechnology.co.uk, by giving us a call on +44 01223 813184, or by clicking here.
